These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17074918)

  • 21. Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis.
    Zhang HC; Wang N; Zhang W; Gu ZC; Liu XY
    Medicine (Baltimore); 2018 Sep; 97(36):e12203. PubMed ID: 30200129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Goudie A; Elder D; Deshmukh H; Szwejkowski BR; Lang CC; George J
    Eur J Heart Fail; 2015 Jan; 17(1):90-7. PubMed ID: 25427720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension: New study REVEALs no survival benefit of warfarin for IPAH.
    Huynh K
    Nat Rev Cardiol; 2016 Jan; 13(1):4. PubMed ID: 26581250
    [No Abstract]   [Full Text] [Related]  

  • 25. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis.
    Wang P; Hu L; Yin Y; Yan D; Zheng H; Zhang J; Li Y
    Thromb Res; 2020 Dec; 196():251-256. PubMed ID: 32920295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and pulmonary arterial hypertension: a systematic review.
    Janda S; Quon BS; Swiston J
    HIV Med; 2010 Nov; 11(10):620-34. PubMed ID: 20408888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation and anticoagulation in pulmonary arterial hypertension.
    Berger G; Azzam ZS; Hoffman R; Yigla M
    Isr Med Assoc J; 2009 Jun; 11(6):376-9. PubMed ID: 19697592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are anticoagulants still indicated in pulmonary arterial hypertension?
    Olschewski H; Rich S
    Pulm Circ; 2018; 8(4):2045894018807681. PubMed ID: 30284508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension.
    Kang BJ; Oh YM; Lee SD; Lee JS
    Korean J Intern Med; 2015 Nov; 30(6):837-45. PubMed ID: 26552459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hypertension in connective tissue diseases: an update.
    Aithala R; Alex AG; Danda D
    Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
    Tam LS; Li EK
    Lupus; 1998; 7(7):495-7. PubMed ID: 9796854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.